Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$82.7M
-6.6% from 2023
Prescriptions
6,082
$13,594.18 per claim
Patients
1,309
779 prescribers
Total spending, 2024
$82.7M
$63,162.56 per patient
Medicare prescription drug plans paid $82.7M for Letairis in 2024, for 6,082 prescriptions and refills to 1,309 patients (down 6.6% from 2023). The average cost per claim was $13,594.18.
California had the highest Medicare cost for Letairis in 2024: $10.6M for 816 claims, followed by Florida ($7.2M).
Frank Cefali, nurse practitioner in New York, NY, had the highest Medicare cost for Letairis in 2024: 111 claims costing $1.4M.
Letairis is made by Gilead Sciences, Inc. (GILD), listed in the Medicare spending data as Gilead Sciences.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Frank Cefali New York, NY | Nurse Practitioner | 111 | 16 | $1.4M |
| Mark V Avdalovic Sacramento, CA | Pulmonary Disease | 72 | 13 | $1.1M |
| Sandeep Sahay Houston, TX |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 634 | 7,924 | 943 | $101.0M |
| 2023 | 545 | 6,231 | 743 | $88.6M |
| 2024 | 779 | 6,082 | 1,309 | $82.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 67 |
| Under 11 |
| $1.1M |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 86 | 13 | $1.1M |
| Terry A Fortin Durham, NC | Cardiology | 83 | Under 11 | $1.1M |
| Rajan Saggar Los Angeles, CA | Pulmonary Disease | 74 | Under 11 | $957K |
| Namita Sood Sacramento, CA | Pulmonary Disease | 56 | Under 11 | $819K |
| Mary Whittenhall Attleboro, MA | Nurse Practitioner | 63 | 12 | $793K |
| Vandana Seeram Jacksonville, FL | Pulmonary Disease | 61 | Under 11 | $774K |
| Zeenat Safdar Houston, TX | Pulmonary Disease | 58 | Under 11 | $764K |
| Mark B Yagan Kansas City, MO | Pulmonary Disease | 52 | Under 11 | $760K |
| Lori G Reed Marietta, GA | Nurse Practitioner | 54 | Under 11 | $703K |
| Chad Miller Austell, GA | Pulmonary Disease | 43 | Under 11 | $647K |
| Kerri A Smith Philadelphia, PA | Critical Care (Intensivists) | 51 | Under 11 | $631K |
| Shelley M Shapiro Los Angeles, CA | Cardiology | 49 | Under 11 | $629K |
| Christina M Eagan Gainesville, FL | Nurse Practitioner | 51 | Under 11 | $604K |
| James H Tarver III Orlando, FL | Cardiology | 46 | Under 11 | $575K |
| Naomi G Habib Phoenix, AZ | Pulmonary Disease | 40 | Under 11 | $512K |
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 39 | Under 11 | $506K |
| Jose Tallaj Birmingham, AL | Advanced Heart Failure and Transplant Cardiology | 40 | Under 11 | $504K |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 39 | Under 11 | $502K |
| Clayton J Shamblin Simpsonville, SC | Pulmonary Disease | 37 | Under 11 | $501K |
| Micah R Fisher Atlanta, GA | Pulmonary Disease | 40 | Under 11 | $483K |
| Mardi Gomberg-Maitland Washington, DC | Cardiology | 37 | Under 11 | $481K |
| Imad S Farrukh West Jordan, UT | Pulmonary Disease | 38 | Under 11 | $471K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Gilead Sciences GILD | 6,082 | $82.7M |